GlassScriptPhysician profile
Cindy A Saiter
NPI 1609880988
$4,388.57
in general payments reported to CMS, 2019-2025
24 companies · $469 in 2025
The $469 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,301 · 2022: $125 · 2023: $950 · 2024: $1,544 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,008 · Travel and Lodging: $955.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,007.84 |
| Travel and Lodging | $955.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $1,171.60 | 2021-2025 | |
| Musculoskeletal Transplant Foundation INC. | $1,112.08 | 2021 | |
| Silk Road Medical, INC. | $717.74 | 2021-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| W. L. Gore & Associates, INC. | $231.95 | 2024-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Conformable Thoracic Stent Graft |
| Medtronic, INC. | $213.83 | 2023-2024 | Hawkone |
| Organogenesis INC. | $187.48 | 2021-2025 | Affinity, Apligraf, Puraply Wound Matrix |
| Pfizer INC. | $131.65 | 2021-2024 | |
| Acadia Pharmaceuticals INC | $107.18 | 2025 | Nuplazid |
| Janssen Pharmaceuticals, INC | $106.06 | 2021-2024 | Xarelto |
| Mimedx Group, INC. | $80.98 | 2024 | |
| Kerecis Limited | $65.16 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Cook Medical LLC | $45.00 | 2021 | |
| Veryan Medical Incorporated | $26.32 | 2023 | Biomimics 3d Vascular Stent System |
| Biocomposites INC | $23.60 | 2025 | Stimulan |
| Bolton Medical INC | $22.69 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $19.99 | 2022-2023 | Artegraft Vascular Graft |
| Paratek Pharmaceuticals, INC. | $18.67 | 2023 | Nuzyra |
| Boston Scientific Corporation | $18.59 | 2025 | Enroute Transcarotid Neuroprotection System |
| Shockwave Medical, INC | $18.58 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbvie INC. | $16.95 | 2023 | |
| Tactile Systems Technology INC | $14.66 | 2022 | |
| Smith+Nephew, INC. | $13.65 | 2023 | Collagenase Santyl, Regranex |
| Angiodynamics, INC. | $12.28 | 2021 | |
| Advanced Oxygen Therapy INC. | $11.88 | 2025 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Saiter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.